Ravindra Sarode MD

Summary

• Ravi Sarode, MD, is a Tenured Professor of Pathology and Internal Medicine (Hematology/Oncology), the Chief of Pathology, and the Medical Director of Clinical Laboratory Services at the University of Texas Southwestern Medical Center in Dallas. He is also the Medical Director of the Division of Transfusion Medicine and Hemostasis. He holds the John H. Childers, MD, Professorship in Pathology. He is a Co-Editor-in-Chief of “Transfusion and Apheresis Science”. He is the past president of the American Society for Apheresis and one of the original writers of the ASFA guidelines. He served as a member of the “Advisory Committee on Blood/Tissue Safety and Availability” advising the Secretary of the DHHS of the USA. He was invited to write anticoagulation reversal guidelines by the American Heart Association (2016-17), the American College of Emergency Physicians (2018-2019), and the Society for Interventional Radiology (2017-18) on hemostasis and transfusion issues before any intervention. His research interests include TTP, HIT, RBCx, APS, anticoagulation monitoring and reversal, rebalanced hemostasis in cirrhosis, and restrictive transfusions to avoid patient harm. He has published more than 220 original articles and many book chapters. As an international coordinating principal investigator, he has completed two randomized clinical trials (RCTs) on warfarin reversal, comparing 4-factor PCC with plasma. He is currently the coordinating international investigator for an RCT comparing low and high doses of 4F-PCC for treating major bleeds in patients on factor Xa inhibitors. He was honored as the Choosing Wisely champion for his work on reducing unnecessary thrombophilia at the annual ASH meeting in San Diego in 2016. His passion is to educate medical professionals on the appropriate use of blood components and laboratory testing to prevent patient harm, utilize resources efficiently, and reduce healthcare costs. He serves on the board of directors for “FWGBD."